KIDRON NADAV (President and CEO) reported 1 transaction at ORAMED PHARMACEUTICALS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/31/2026ACC: 0001213900-26-037447
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-44.82K
Net shares
Net seller
$148.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
44.82K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−44.82K
Price / share
$3.31
Trade value
$148.35K
% of position
1.3%
3/30/2026
3.47M→3.42M
Total
Net shares
−44.82K
Net value
-$148.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/30/2026 | F · Tax Withholding | −44.82K | $3.31 | $148.35K | 1.3% | 3.47M | 3.42M |
| Total | −44.82K | -$148.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned126K
Total
126K indirect126K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 126K | Indirect |
| Total | 126K | 126K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported